TABLE 4.
Effects of beta-carotene supplements vs. placebo or no intervention on cause-specific mortality.
| Mortality cause | No. of trials | Risk ratio (95% CI) | I2 (%) | Model used |
| Cancer | 13 | 0.98 (0.90, 1.07) | 37.0 | Random effects |
| Colorectal cancer | 2 | 0.97 (0.68, 1.38) | 0.0 | Random effects |
| Esophagus and stomach cancer | 2 | 0.93 (0.82, 1.06) | 0.0 | Random effects |
| Prostate cancer | 3 | 0.93 (0.73, 1.18) | 0.0 | Random effects |
| Lung cancer | 5 | 1.14 (1.02, 1.27)* | 3.0 | Random effects |
| Lung cancer in smokers | 2 | 1.14 (1.03, 1.27)* | 0.0 | Random effects |
| Lung cancer in mixed smokers and non-smokers | 3 | 0.94 (0.74, 1.20) | 0.0 | Random effects |
| Urinary tract cancer | 2 | 0.82 (0.55, 1.21) | 0.0 | Random effects |
| Pancreatic cancer | 2 | 0.85 (0.62, 1.16) | 0.0 | Random effects |
| Other cancer | 6 | 0.86 (0.70, 1.06) | 0.0 | Random effects |
| Cardiovascular disease | 12 | 1.04 (0.98, 1.11) | 0.0 | Random effects |
| Cerebrovascular disease | 5 | 0.94 (0.82, 1.06) | 0.0 | Random effects |
| HIV-related causes | 2 | 0.55 (0.33, 0.92)* | 0.0 | Random effects |
| Non-cancer, non-vascular cause | 5 | 1.04 (0.95, 1.14) | 0.0 | Random effects |
*Statistically significant.